|
|
|
Insider
Information: |
Baker Bros Advisors Llc |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
287,772 |
|
Indirect Shares
|
13,789,697 |
|
|
Direct
Value |
$59,327,707 |
|
|
Indirect Value
|
$1,262,987,005 |
|
|
Total
Shares |
14,077,469 |
|
|
Total
Value |
$1,322,314,712 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2012-06-19 |
0 |
2012-06-19 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-11-21 |
288 |
2013-06-05 |
860,515 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2013-05-17 |
154,001 |
2013-05-17 |
326,648 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
|
0 |
2013-10-24 |
40,308 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2014-06-20 |
1,520 |
2014-06-20 |
367,326 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2016-05-11 |
131,963 |
2016-05-11 |
6,198,972 |
Premium* |
|
Kymera Therapeutics, Inc. |
KYMR |
|
|
0 |
2024-03-28 |
5,995,928 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
Director |
|
2014-04-23 |
4 |
OE |
$65.10 |
$3,645,600 |
I/I |
56,000 |
219,614 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2014-06-20 |
4 |
OE |
$60.45 |
$1,798,388 |
I/I |
29,750 |
223,864 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
6,703,611 |
6,103,033 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
131,965 |
66,154 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,392 |
6,103,727 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
1,670 |
6,104,562 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-06-22 |
4/A |
A |
$0.00 |
$0 |
D/D |
131,963 |
66,153 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-06-22 |
4/A |
A |
$0.00 |
$0 |
I/I |
6,703,606 |
6,103,031 |
0 |
- |
|
33 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|